JCR Pharmaceuticals is a Japanese pharmaceutical company specialising in the research, manufacture and sale of pharmaceutical products for the treatment of rare and genetic diseases. As part of his working visit to Japan, the Minister of the Economy, Franz Fayot, concluded an agreement with JCR Pharmaceuticals pour établir la plate-forme logistiqu on 2 December in Tokyo to establish the company's European logistics platform in Luxembourg.
-
Franz Fayot signing the agreement.
-
(fr. l. to r.) Takayo Egawa, Corporate Officer and Director, International Affairs Officer of JCR Pharmaceuticals ; Shin Ashida, Chairman & CEO of JCR Pharmaceuticals ; Franz Fayot, Minister of the Economy ; Dr. Mathias Schmidt, CEO of JCR USA and Director of JCR Luxembourg SA ; Takashi Suetsuna, Director on the Board of JCR Pharmaceuticals
While initial contacts between Luxembourg and JCR Pharmaceuticals took place as early as 2017, the Japanese company has finally decided to build a logistics platform in Luxembourg on a plot of land of more than 10,000 m2 in the "Wolser" business park between Bettembourg and Dudelange for the packaging, labelling and shipping of JCR's investigational and commercial products throughout Europe and beyond. Listed on the stock exchange, JCR Pharmaceuticals employs a total of around 800 people. The company is also active in the US, Europe, Asia and Latin America.
At the agreement signing ceremony, the Minister of the Economy, Franz Fayot, said: "The JCR project in Luxembourg underlines the attractiveness of Luxembourg as a strategic hub for international companies to access the European market and beyond. With the JCR project, we are strengthening two of our strategic sectors to diversify our economy: health technologies and logistics. The activities to be developed by JCR will complement the existing activities of LuxairCARGO Pharma Hub. Our agreement with JCR will strengthen our position as a resilient pharmaceutical supply chain ecosystem."
"I am honoured to sign this agreement with Luxembourg," said Shin Ashida, president and CEO of JCR. "We have been in discussions with Luxembourg for JCR's strategic global expansion for several years. To adapt to the changing environment of the pharmaceutical industry, a phased approach was reasonable, such as establishing a European packaging, labelling and logistics centre for the global distribution of our investigational and commercial products beyond Japan. This agreement reflects Luxembourg's generous understanding and cooperation and is essential for JCR in its global expansion."
Press release by the Ministry of the Economy